ArticleOncoimmunology2025

Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade.

Pedro Rocha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.